Additionally, enhanced anti-tumor immune activity, including increased CD8 + T cell responses and reduced Tregs (Fig. 5B–G) [68, 69], may further limit tumor cells’ access to the vasculature. The gene discussed is CD8A; the disease is neoplasm.